Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reduced pro-inflammatory dendritic cell phenotypes are a potential indicator of successful peanut oral immunotherapy.

PloS one - 1 Jan 2022

Anvari Sara, Watkin Levi B, Minard Charles G, Schuster Kimberly, Hassan Oluwatomi, Anagnostou Aikaterini, Orange Jordan S, Corry David B, Davis Carla M

Abstract excerpt

Dendritic cells are important mediators in the early presentation of antigen and regulation of the differentiation of T cells. Peanut oral immunotherapy (POIT) results in desensitization in most peanut allergic individuals (responders), but not in others due to allergic reactions (non-responders). Delineation of early immunologic changes contributing to desensitization would help clarify the POIT mechanism of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arachis
Share to Child

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dendritic Cells

Share to Desensitization, Immunologic

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 35617270
DOI: 10.1371/journal.pone.0264674
PMCID: PMC9135258

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reduced pro-inflammatory dendritic cell phenotypes are a potential indicator of successful peanut oral immunotherapy.PMID 35617270Read ↗

Peanut oral immunotherapy differentially suppresses clonally distinct subsets of T helper cellsSemantic proximity Read ↗

Peanut oral immunotherapy differentially suppresses clonally distinct subsets of T helper cellsSemantic proximity Read ↗

High-dimensional immune profiles correlate with phenotypes of peanut allergy during food-allergic reactions.Semantic proximity Read ↗

Understanding the Variability of Peanut‐Oral Immunotherapy Responses by Multi‐Omics Profiling of Immune CellsSemantic proximity Read ↗

Oral immunotherapy with omalizumab reverses the Th2 cell-like programme of regulatory T cells and restores their function.Semantic proximity Read ↗

Changes in markers associated with dendritic cells driving the differentiation of either TH2 cells or regulatory T cells correlate with clinical benefit during allergen immunotherapySemantic proximity Read ↗

Identification and analysis of peanut-specific effector T and regulatory T cells in children allergic and tolerant to peanutSemantic proximity Read ↗

Dynamic Regulation of CD300b, and CD300f on Myeloid Cells in Oral ImmunotherapySemantic proximity Read ↗

Ara h 2–expressing cucumber mosaic virus–like particle (VLP Peanut) induces in vitro tolerogenic cellular responses in peanut-allergic individualsSemantic proximity Read ↗

Immuno‐epigenomic analysis identifies attenuated interferon responses in naïve CD4 T cells of adolescents with peanut and multi‐food allergySemantic proximity Read ↗

Successful immunotherapy induces previously unidentified allergen-specific CD4+ T-cell subsetsSemantic proximity Read ↗

Integrative transcriptomic analysis reveals key drivers of acute peanut allergic reactionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.